Significance of inhibin in reproductive pathophysiology and current clinical applications

Philip Kumanov, Kalyana C. Nandipati, Analia Tomova, Raliza Robeva, Ashok Agarwal

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

The human reproductive process is regulated by complex mechanisms that involve many organs, including the brain, gonads and endocrine system. It has been more than 70 years since the name 'inhibin' was used to describe a substance produced in the gonads that negatively regulates pituitary secretion. Inhibin B controls FSH secretion via a negative feedback mechanism. It is a glycoprotein hormone secreted by the Sertoli cells of the testis and granulosa and theca cells of the ovary. Serum inhibin B concentrations are positively related to testicular volume and sperm counts. Current understanding of inhibin physiology and pathology in the human suggests that inhibin B may be of importance as a marker of Sertoli cell function in men with infertility and as a prognostic indicator in women undergoing ovulation induction therapy. Inhibin concentrations are elevated in patients with granulosa cell tumours and in post-menopausal women with mucinous ovarian cancers. Immunoreactivity against the inhibin α-subunit was identified in all cases of adrenal cortical adenoma and carcinoma, and levels are suppressed in the malignant prostate disease. This article discusses the structure, regulation and clinical use of inhibin and other related substances.

Original languageEnglish
Pages (from-to)786-796
Number of pages11
JournalReproductive BioMedicine Online
Volume10
Issue number6
StatePublished - Jun 2005
Externally publishedYes

Fingerprint

Inhibins
Sertoli Cells
Gonads
Adrenocortical Adenoma
Granulosa Cell Tumor
Theca Cells
Adrenocortical Carcinoma
Endocrine System
Sperm Count
Ovulation Induction
Granulosa Cells
Ovarian Neoplasms
Infertility
Names
Testis
Prostate
Ovary
Glycoproteins
Hormones
Pathology

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Significance of inhibin in reproductive pathophysiology and current clinical applications. / Kumanov, Philip; Nandipati, Kalyana C.; Tomova, Analia; Robeva, Raliza; Agarwal, Ashok.

In: Reproductive BioMedicine Online, Vol. 10, No. 6, 06.2005, p. 786-796.

Research output: Contribution to journalReview article

Kumanov, Philip ; Nandipati, Kalyana C. ; Tomova, Analia ; Robeva, Raliza ; Agarwal, Ashok. / Significance of inhibin in reproductive pathophysiology and current clinical applications. In: Reproductive BioMedicine Online. 2005 ; Vol. 10, No. 6. pp. 786-796.
@article{f89481cd9fd24cc7a4264ea7d17b4079,
title = "Significance of inhibin in reproductive pathophysiology and current clinical applications",
abstract = "The human reproductive process is regulated by complex mechanisms that involve many organs, including the brain, gonads and endocrine system. It has been more than 70 years since the name 'inhibin' was used to describe a substance produced in the gonads that negatively regulates pituitary secretion. Inhibin B controls FSH secretion via a negative feedback mechanism. It is a glycoprotein hormone secreted by the Sertoli cells of the testis and granulosa and theca cells of the ovary. Serum inhibin B concentrations are positively related to testicular volume and sperm counts. Current understanding of inhibin physiology and pathology in the human suggests that inhibin B may be of importance as a marker of Sertoli cell function in men with infertility and as a prognostic indicator in women undergoing ovulation induction therapy. Inhibin concentrations are elevated in patients with granulosa cell tumours and in post-menopausal women with mucinous ovarian cancers. Immunoreactivity against the inhibin α-subunit was identified in all cases of adrenal cortical adenoma and carcinoma, and levels are suppressed in the malignant prostate disease. This article discusses the structure, regulation and clinical use of inhibin and other related substances.",
author = "Philip Kumanov and Nandipati, {Kalyana C.} and Analia Tomova and Raliza Robeva and Ashok Agarwal",
year = "2005",
month = "6",
language = "English",
volume = "10",
pages = "786--796",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Significance of inhibin in reproductive pathophysiology and current clinical applications

AU - Kumanov, Philip

AU - Nandipati, Kalyana C.

AU - Tomova, Analia

AU - Robeva, Raliza

AU - Agarwal, Ashok

PY - 2005/6

Y1 - 2005/6

N2 - The human reproductive process is regulated by complex mechanisms that involve many organs, including the brain, gonads and endocrine system. It has been more than 70 years since the name 'inhibin' was used to describe a substance produced in the gonads that negatively regulates pituitary secretion. Inhibin B controls FSH secretion via a negative feedback mechanism. It is a glycoprotein hormone secreted by the Sertoli cells of the testis and granulosa and theca cells of the ovary. Serum inhibin B concentrations are positively related to testicular volume and sperm counts. Current understanding of inhibin physiology and pathology in the human suggests that inhibin B may be of importance as a marker of Sertoli cell function in men with infertility and as a prognostic indicator in women undergoing ovulation induction therapy. Inhibin concentrations are elevated in patients with granulosa cell tumours and in post-menopausal women with mucinous ovarian cancers. Immunoreactivity against the inhibin α-subunit was identified in all cases of adrenal cortical adenoma and carcinoma, and levels are suppressed in the malignant prostate disease. This article discusses the structure, regulation and clinical use of inhibin and other related substances.

AB - The human reproductive process is regulated by complex mechanisms that involve many organs, including the brain, gonads and endocrine system. It has been more than 70 years since the name 'inhibin' was used to describe a substance produced in the gonads that negatively regulates pituitary secretion. Inhibin B controls FSH secretion via a negative feedback mechanism. It is a glycoprotein hormone secreted by the Sertoli cells of the testis and granulosa and theca cells of the ovary. Serum inhibin B concentrations are positively related to testicular volume and sperm counts. Current understanding of inhibin physiology and pathology in the human suggests that inhibin B may be of importance as a marker of Sertoli cell function in men with infertility and as a prognostic indicator in women undergoing ovulation induction therapy. Inhibin concentrations are elevated in patients with granulosa cell tumours and in post-menopausal women with mucinous ovarian cancers. Immunoreactivity against the inhibin α-subunit was identified in all cases of adrenal cortical adenoma and carcinoma, and levels are suppressed in the malignant prostate disease. This article discusses the structure, regulation and clinical use of inhibin and other related substances.

UR - http://www.scopus.com/inward/record.url?scp=20444403340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444403340&partnerID=8YFLogxK

M3 - Review article

VL - 10

SP - 786

EP - 796

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 6

ER -